MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
about
MiR-29a: a potential therapeutic target and promising biomarker in tumors.Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System.Egr2-dependent microRNA-138 is dispensable for peripheral nerve myelination.
P2860
MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
@en
MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
@nl
type
label
MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
@en
MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
@nl
prefLabel
MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
@en
MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
@nl
P2093
P2860
P356
P1476
MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6
@en
P2093
P2860
P304
P356
10.1002/JCB.26426
P50
P577
2017-12-12T00:00:00Z